(Q41706764)

7 October 2017

title

Production of Immunogenic HIV-1 Viruslike Particles in Stably Engineered Monkey Cell Lines (English)

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

4 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707639

4 November 2022

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

4 November 2022

author name string

Haynes JR

1

1 reference

7 October 2017

Cao SX

2

1 reference

7 October 2017

Rovinski B

3

1 reference

7 October 2017

Sia C

4

1 reference

7 October 2017

James O

5

1 reference

7 October 2017

Dekaban GA

6

1 reference

7 October 2017

Klein MH

7

1 reference

7 October 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1707639

4 November 2022

publication date

1 January 1991

1 reference

full work available at URL

7 October 2017

http://www.liebertpub.com/doi/pdf/10.1089/aid.1991.7.17

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

AIDS Research and Human Retroviruses

4 November 2022

published in

1 reference

7 October 2017

volume

7

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

17-27

1 reference

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120

7 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine

4 November 2022

2

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies

4 November 2022

3

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

4 November 2022

4

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies

4 November 2022

5

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

4 November 2022

6

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

HIV antibodies and vaccine design

4 November 2022

7

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Linear versus conformational variation of V3 neutralization domains of HIV-1 during experimental and natural infection

4 November 2022

9

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization

4 November 2022

10

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

4 November 2022

11

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Isolate- and group-specific immune responses to the envelope protein of human immunodeficiency virus induced by a live recombinant vaccinia virus in macaques

4 November 2022

13

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.

4 November 2022

14

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses

4 November 2022

15

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS.

4 November 2022

16

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Perspectives on developing anti-idiotype-based vaccines for controlling HIV infection

4 November 2022

18

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Vaccine protection against simian immunodeficiency virus infection

4 November 2022

19

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

A formalin-inactivated whole SIV vaccine confers protection in macaques

4 November 2022

20

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Prospects for the control of AIDS by immunizing seropositive individuals

4 November 2022

21

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection

4 November 2022

22

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Vaccination against SIV infection and disease

4 November 2022

23

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals

4 November 2022

24

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells

4 November 2022

25

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector

4 November 2022

26

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles

4 November 2022

28

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV

4 November 2022

29

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Nucleotide sequence of the AIDS virus, LAV

4 November 2022

30

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Journal of Molecular and Applied Genetics

4 November 2022

31

1

327

Southern PJ

1982

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus

4 November 2022

32

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Human metallothionein genes--primary structure of the metallothionein-II gene and a related processed gene

4 November 2022

33

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Constitutive, long-term production of human interferons by hamster cells containing multiple copies of a cloned interferon gene

4 November 2022

34

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

A recessive cellular mutation in v-fes-transformed mink cells restores contact inhibition and anchorage-dependent growth

4 November 2022

35

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

4 November 2022

36

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

4 November 2022

37

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

4 November 2022

38

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Molecular biology of HIV: new insights into the virus life-cycle

4 November 2022

39

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA

4 November 2022

41

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region

4 November 2022

42

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA

4 November 2022

43

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

4 November 2022

Retroviruses

44

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Hyperinducible gene expression from a metallothionein promoter containing additional metal-responsive elements

4 November 2022

46

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency

4 November 2022

47

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells

4 November 2022

48

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptors

4 November 2022

49

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

4 November 2022

50

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Inhibition of serum-enhanced HIV-1 infection of U937 monocytoid cells by recombinant soluble CD4 and anti-CD4 monoclonal antibody

4 November 2022

51

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals

4 November 2022

52

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides

4 November 2022

53

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response.

4 November 2022

54

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide

4 November 2022

58

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Structural features of T-cell recognition: applications to vaccine design

4 November 2022

60

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

4 November 2022

61

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins.

4 November 2022

62

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.

4 November 2022

63

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine

4 November 2022

64

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Identification of a potent synthetic HIV1 immunogen compromising gag-P24 tandem T- and B-cell epitopes

4 November 2022

65

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence

4 November 2022

66

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions

4 November 2022

67

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.

4 November 2022

68

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus

4 November 2022

69

1 reference

https://api.crossref.org/works/10.1089/AID.1991.7.17

4 November 2022

Identifiers

0 references

1 reference